President Trump just lit a political fuse. In a surprise move, he ordered the FDA to fast‑track psychedelic drugs for veterans, tying medical desperation to election‑year power. Lives hang in the balance. So do federal drug rules, “Right to Try” laws, and voting norms. Supporters call it courage. Critics see calculated overreac… Continues… Trump’s order forces a collision between science, suffering, and politics. By demanding faster FDA action on psychedelics already tagged as “breakthrough therapies,” he’s betting that ibogaine, MDMA, and similar treatments can deliver dramatic relief for veterans with PTSD, depression, and traumatic brain injuries. The directive pushes the FDA...
Continues…